Brain Cancer Treatment Centers

In the US, about 180,000 women develop it each year. Brain Cancer Treatment Centers The disease can also occur in men, although cancer of the male breast accounts for less than 1 in 100 cases. The risk of it increases with age, doubling every 10 years.

The disease is most commonly diagnosed in women over age 50. Very few women under age 30 develop it. Despite the rise in incidence, there has been a small drop in the number of deaths in the recent years and only about one-fifth of cases prove fatal. This reduction is due to improvements in treatment and the increased use of mammography for screening, which means that tumors can be detected early, when they often respond well to treatment.

Screening may reduce the number of deaths in women over age 50 by up to 4 in 10. In the US, many doctors recommend that women over age 40 have a mammogram every 1-2 years and every year over age 50. A cancerous tumor may first develop in the breast lobules (the structures in the breast that produce milk). A tumor that originates in the milk ducts may lead to Paget’s disease of the breast. Tumors may spread to other organs, such as the lungs or the liver, before being detected.

It is a cancer that originates in the breast tissue of women and men. It can spread to the lymph nodes under the arm before diagnosis. With advanced disease, metastasis can be seen in many body organs, including bone, brain, lung, liver and skin.

Causes:

The underlying cause of most is unclear. However, some risk factors have been identified, many of which suggest that the female hormone estrogen is an important factor in the development and progress of the disease. It is known that women who have their first menstrual period before age 11, or who have a late menopause, seem to be at increased risk of developing this cancer, probably because they are exposed to high levels of estrogen for longer. The number of menstrual cycles before a first pregnancy is also significant. And a woman who has her first child before age 20 has chances. Breast feeding is thought to have an additional protective effect.

Risk factors for developing it include

. Early onset of menses or late menopause

. First pregnancy after age 30

. Family history of the disease

. Radiation exposure

Possible risk factors include

. High fat diet

. Excessive alcohol intake

. Estrogen replacement therapy

. Oral contraceptive use

Symptoms:

It is usually manifest as a painless lump anywhere in the breast or under the arm. Occasionally, its symptoms can be more subtle, such as:

. An inverted nipple

. Bloody discharge from the nipple

. Changes in the skin overlying the breast making it resemble the skin of an orange.

Diagnosis:

Any Breast pain or lumps felt on physical examination by a woman or her physician and any lumps found on mammography (Radiography) should be considered for biopsy. Lumps seen on mammography, but not palpable on examination can be located by ultrasound or mammogram for biopsy. If a diagnosis of it is established, staging tests include:

. Liver function tests

. Alkaline phosphates test to check for bone disease

. Chest X-ray (Radiography)

. Bone Scan (Nuclear Medicine)

Complications:

Complications of it are related to areas of metastasis:

Lung Cancer Secrets Revealed Click here

. Metastasis to bone can cause pain, bone fractures or elevated calcium levels in the blood.

. Metastasis to the brain or spinal cord can cause seizures, headaches, weakness, numbness or confusion.

. Metastasis to the lungs can cause breathing difficulty, chest pain or swelling of the face and neck.

Treatment: Self Treatment:

. A well balanced diet should be maintained. Once a diagnosis of it is made all estrogen medication should be stopped, including birth control pills.

Medical Treatment:

Many women will require additional drug therapy after surgery to prevent it from returning. Either tamoxifen (a hormonal pill) or chemotherapy (intravenous medication) may be recommended, depending on the type of tumor. More advanced case is also treated with chemotherapy or hormonal therapy.

Surgical Treatment:

Two alternative initial treatments for it are:

. Lumpectomy with lymph node dissection followed by Radiation Therapy to the breast.

. Mastectomy (mastectomy, partial or mastectomy, modified radical)

Prevention:

Early detection of it by regular beast self-examination and regular mammography (Radiography) screening is important. A low – fat diet and moderate alcohol intake may be important. Some researchers theorize that exercise for preadolescent girls may be helpful as it delays the age of onset of menstruation.

lung cancer treatment breakthroughs Click here

About the Author

lung cancer best treatment Click here

Gene-based lung cancer treatment video

Flora Flor-Essence …

Life Over Cancer: The Block Center Program for Integrative Cancer Treatment $14.47 Dr. Keith Block is at the global vanguard of innovative cancer care. As medical director of the Block Center for Integrative Cancer Treatment in Evanston, Illinois, he has treated thousands of patients who have lived long, full lives beyond their original prognoses. Now he has distilled almost thirty years of experience into the first book that gives patients a systematic, research-based plan for …

Herbal Medicine, Healing & Cancer: A Comprehensive Program for Prevention and Treatment $13.68 More and more people who have been diagnosed with cancer or related illnesses embrace alternative medicines, and seek out holistic practitioners who use vitamins, herbs, nutrition, homeopathy, and acupuncture to treat the disease. This long-awaited book by Donald Yance–one of the nation’s most respected herbalists–is a major contribution to the literature of natural healing and cancer….

Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials $10.39 Cancer Clinical Trials is a comprehensive, no-nonsense, and readable guide for anyone who is considering therapeutic options in addition to standard cancer therapy. The book seeks to share knowledge about cancer clinical trials with people living with cancer, their families and loved ones. It will help readers decide if a clinical trial is a good option for them, to choose an appropriate trial, an…

Lung Cancer $189.58 Lung cancer remains the leading cause of cancerrelated death in men, and in women, it has surpassed even breast cancer. According to the American Cancer Society, in 2001, there will be about 169,500 new cases of lung cancer in the United States: 90,700 among men and 78,800 among women. Lung Cancer is the second installment in the M. D. Anderson Cancer Care Series, featuring the current standard approach to lung cancer care from the experts at M. D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include the clinical examination of patients with suspected lung cancer, thoracic imaging techniques for nonsmall cell and small cell lung cancer, pathology of lung cancer, treatment and management of nonsmall and smallcell lung cancer, including the role of guidelines and clinical pathways, molecular events in lung cancer and implications for prevention and therapy, palliation, and much more. Each of the 15 chapters ends with an uptodate list of suggested readings, as well as key practice points highlighting the most important principles and practices of each chapter for ataglance reference. Over 50 illustrations and 40 tables round out the text. This thorough, practical volume is the essential clinical guide for oncologists, surgeons, and all physicians involved in the care of patients with lung cancer. Author: Fossella, Frank V./ Komaki, Ritsuko/ Putnam, Joe B. Series Title: M.D. Anderson Cancer Care Series Binding Type: Paperback Number of Pages: 328 Publication Date: 2003/01/01 Language: English Dimensions: 9.28 x 6.20 x 0.56 inches

Cancer and Leukemia Group B $59 High Quality Content by WIKIPEDIA articles! Cancer and Leukemia Group B (CALGB) is a cancer research cooperative group in the United States. CALGB research is focused on seven major disease areas: leukemia, lymphoma, breast cancer, lung cancer, gastrointestinal malignancies, genito-urinary malignancies, and melanoma. In each of these areas, multi-modality treatment programs are designed by national experts in an attempt to cure more patients with cancer. Treatment protocols are carefully developed and monitored and are often coupled with studies of cancer biology, quality of life, pharmacology and cost-effectiveness measures so that improvements in therapy can be placed in the proper clinical perspective in today’s health care marketplace. The CALGB pays particular attention to the rights of cancer patients participating in clinical research studies by working with the Department of Health and Human Services’ Office for Human Research Protection (OHRP). CALGB is headquartered at the University of Chicago in Chicago, Illinois and maintains its statistical center at Duke University in Durham, North Carolina.

Lung Cancer $1.99 Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.This outstanding team from the M.D. Anderson Cancer Center takes an evidence-based approach to lung cancer management and explains these advances in depth. Comprehensive treatment guidelines are provided, the third edition of Lung Cancer explores vital issues such as:Lung cancer susceptibility and risk assessmentThe pathology and pathogenesis of peripheral lung adenocarcinoma including bronchioloalveolar carcinomaScreening for early detectionAdvances in molecular and genetic markersThe detection and treatment of pre-neoplastic lesions and screening for lung cancerNovel therapies such as angiogenesis and multi-tyrosine kinase inhibitorsLung Cancer is a concise summary of advances in lung cancer clinical research and treatment for the clinician and is an invaluable reference for respiratory physicians, medical oncologists, clinical and surgical oncologists.

Lung Cancer $119 Lung cancer remains the leading cause of cancer-related death in men, and in women, it has surpassed even breast cancer. According to the American Cancer Society, in 2001, there will be about 169,500 new cases of lung cancer in the United States: 90,700 among men and 78,800 among women. Lung Cancer is the second installment in the M. D. Anderson Cancer Care Series, featuring the current standard approach to lung cancer care from the experts at M. D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include the clinical examination of patients with suspected lung cancer, thoracic imaging techniques for non-small cell and small cell lung cancer, pathology of lung cancer, treatment and management of non-small and small-cell lung cancer, including the role of guidelines and clinical pathways, molecular events in lung cancer and implications for prevention and therapy, palliation, and much more. Each of the 15 chapters ends with an up-to-date list of suggested readings, as well as "key practice points" highlighting the most important principles and practices of each chapter for at-a-glance reference. Over 50 illustrations and 40 tables round out the text. This thorough, practical volume is the essential clinical guide for oncologists, surgeons, and all physicians involved in the care of patients with lung cancer.

Lung Cancer $121.56 Lung cancer remains the leading cause of cancer-related death in men, and in women, it has surpassed even breast cancer. According to the American Cancer Society, in 2001, there will be about 169,500 new cases of lung cancer in the United States: 90,700 among men and 78,800 among women. LUNG CANCER is the second installment in the M. D. Anderson Cancer Care Series, featuring the current standard approach to lung cancer care from the experts at M. D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include the clinical examination of patients with suspected lung cancer, thoracic imaging techniques for non-small cell and small cell lung cancer, pathology of lung cancer, treatment and management of non-small and small-cell lung cancer, including the role of guidelines and clinical pathways, molecular events in lung cancer and implications for prevention and therapy, palliation, and much more. Each of the 15 chapters ends with an up-to-date list of suggested readings, as well as key practice points highlighting the most important principles and practices of each chapter for at-a-glance reference. Over 50 illustrations and 40 tables round out the text. This thorough, practical volume is the essential clinical guide for oncologists, surgeons, and all physicians involved in the care of patients with lung cancer.